FINANCE: Aylesbury Vale clinical commissioning group finished 2012-13 with a £1.3m surplus, despite overspends on acute care.
The surplus was in line with the forecast position.
However some quality, innovation, productivity and prevention schemes underperformed. The local “right care” and “ImPact” programmes under achieved by 67 per cent and 82 per cent respectively.
These were offset by overperformance on prescribing and running costs.